Share
capital
£m
Share
premium
account
£m
Own
shares
£m
Other
reserves
£m
Translation
reserves
£m
Retained
earnings
£m
Equity
attributable
to equity
holders of
the parent
£m
Non-
controlling
interests
£m
Total
equity
£m
1 January 201733.1177.1(8.0)133.957.5234.3627.90.4628.3
Net profit for the year97.197.10.297.3
Exchange differences on translation of overseas operations(11.6)(11.6)(0.1)(11.7)
Actuarial losses on defined benefit pension schemes net of deferred tax5.75.75.7
Total comprehensive income for the year(11.6)102.891.20.191.3
Acquired in the year/settlement of share options0.8(0.7)0.10.1
Share-based payments7.87.87.8
Deferred tax on share-based payment transactions0.60.60.6
Dividends paid(30.6)(30.6)(30.6)
31 December 201733.1177.1(7.2)141.045.9307.1697.00.5697.5
Net profit for the year103.2103.20.4103.6
Exchange differences on translation of overseas operations16.016.0(0.2)15.8
Actuarial gains on defined benefit pension schemes net of deferred tax(1.3)(1.3)(1.3)
Total comprehensive income for the year16.0101.9117.90.2118.1
Return of capital to shareholders and redemption of B shares(0.2)(0.2)(0.2)
Acquired in the year/settlement of share options(7.6)(3.4)0.4(10.6)(10.6)
Share-based payments3.83.83.8
Deferred tax on share-based payment transactions(0.2)(0.2)(0.2)
Dividends paid(81.8)(81.8)(81.8)
31 January 201833.1177.1(14.8)141.461.9327.2725.90.7726.6

Included in other reserves is the capital redemption reserve of £129.8m (2017: £129.8m) and the share-based payments reserve of £10.8m (2017: £10.4m).

The own shares reserve represents the cost of shares in Bodycote plc purchased in the market. At 31 December 2018, 1,839,860 (2017: 1,171,190) ordinary shares of 17 3/11p each were held by the Bodycote International Employee Benefit Trust to satisfy share-based payments under the Group's incentive schemes (see note 27).